Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 14,745 | 622 | 240 | 934 | 605 |
| Gross Profit | 14,745 | 622 | 240 | 934 | 605 |
| Operating Expenses | 358,927 | 362,872 | 351,538 | 331,214 | 221,485 |
| Operating Income | -344,182 | -362,250 | -351,298 | -330,280 | -220,880 |
| Interest Expense | 154,327 | 129,198 | 63,515 | 14,849 | 9,074 |
| Other Income | 84,864 | -92,444 | -2,473 | -4,710 | 3,921 |
| Pre-tax Income | -413,645 | -583,892 | -417,286 | -349,839 | -226,033 |
| Income Tax | N/A | -40 | 34 | 9 | -1,846 |
| Net Income Continuous | -413,645 | -583,852 | -417,320 | -349,848 | -224,187 |
| Minority Interests | -81 | -656 | -753 | -3,058 | -2,336 |
| Net Income | $-413,564 | $-583,196 | $-416,567 | $-346,790 | $-221,851 |
| EPS Basic Total Ops | -0.59 | -1.15 | -1.04 | -0.89 | -0.59 |
| EPS Basic Continuous Ops | -0.59 | -1.15 | -1.04 | -0.90 | -0.59 |
| EPS Diluted Total Ops | -0.62 | -1.15 | -1.04 | -0.89 | -0.59 |
| EPS Diluted Continuous Ops | -0.59 | -1.15 | -1.04 | -0.90 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -0.99 | N/A | N/A | N/A |
| EBITDA(a) | $-305,530 | $-301,479 | $-315,438 | $-315,577 | $-207,347 |